Akamis Bio logo
VerifiedBiotechnology Research· Founded 2010

Akamis Bio

Headquartered in Cambridge, Massachusetts, Akamis Bio is a clinical-stage oncology company developing systemically administered immunotherapies to treat solid tumors, initially in patients with locally advanced rectal cancer (LARC). Its proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform is designed to deliver novel immunotherapeutic proteins, biomolecules and transgene combinations to treat solid tumors, with its lead clinical-stage program, NG-350A, driving intratumoral expression of a CD40 agonist monoclonal antibody. To learn more, please visit

7-day free trial · no credit card

HeadquartersCambridge, United StatesEmployees35(11 to 50)Founded year2010Websiteakamisbio.comLinkedIn profileLinkedIn

Verified contacts

29

available on Kipplo

LinkedIn employees

35

11 to 50 range

Open roles

no listings

Distinct roles

24

indexed titles

Tech stack

1

tools in use

Monthly traffic

93

organic / mo

Sign up free to see all 29 verified contacts at Akamis Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

29 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Akamis Bio

24 distinct titles indexed · top 10 shown.

  • 2associate scientist
  • 2senior principal scientist
  • 1accounting bookkeeper
  • 1bookkeeper
  • 1chief executive officer
  • 1clinical trial manager
  • 1director, facilities and it
  • 1facilities officer
  • 1finance manager
  • 1head of people and culture
  • +14more titles

Sign up to unlock all 29 contacts at Akamis Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 29 verified contacts at Akamis Bio

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Akamis Bio | Kipplo Discover